MedImmune News
Most Popular MedImmune Story
Swine flu could be FluMist's moment
Swine flu could be MedImmune's watershed moment. The company says it's gearing up to produce about five times as much H1N1 flu vaccine as it had expected, the New York Times reports. With Read more...
Latest Headlines
- July 6, 2011
- September 2, 2010
- December 23, 2009
- August 20, 2009
- July 31, 2009
- January 7, 2009
- July 1, 2008
- December 21, 2007
- October 24, 2007
- October 15, 2007
- September 20, 2007
- September 10, 2007
- September 6, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
